pp-111 Gel
Dossier type
CTD
Dossier status
Ready to file
Country of origin
Japan
Comments
Indication: Acne vulgaris in patients requiring topical dermatologic therapy
Clinical stage: Approved/marketing authorization obtained in Japan with product registration completed
Modality: Small molecule / topical formulation
Mechanism / Target: Topical anti‑acne action via dermatologic therapeutic effects (mechanism specific to formulation)
Route / form: Topical application (gel/ointment)
Differentiation: Developed for localized acne management with approval in Japan, tailored to patient skin treatment needs
Manufacturer #492
Leading clinical‑stage dermatology pharma with broad R&D, manufacturing and commercialization focus on skin diseases, expanding into metabolic and specialty areas. It pursues strategic collaborations and global development through regional subsidiaries and innovation partnerships. The organization emphasises quality, regulatory compliance and expanding patient‑centric solutions.